Ontology highlight
ABSTRACT: Background/aims
Helicobacter pylori eradication rates are decreasing because of increases in clarithromycin resistance. Thus, finding an easy and accurate method of detecting clarithromycin resistance is important.Methods
We evaluated 70 H. pylori isolates from Korean patients. Dual-labeled peptide nucleic acid (PNA) probes were designed to detect resistance associated with point mutations in 23S ribosomal ribonucleic acid gene domain V (A2142G, A2143G, and T2182C). Data were analyzed by probe-based fluorescence melting curve analysis based on probe-target dissociation temperatures and compared with Sanger sequencing.Results
Among 70 H. pylori isolates, 0, 16, and 58 isolates contained A2142G, A2143G, and T2182C mutations, respectively. PNA probe-based analysis exhibited 100.0% positive predictive values for A2142G and A2143G and a 98.3% positive predictive value for T2182C. PNA probe-based analysis results correlated with 98.6% of Sanger sequencing results (?-value=0.990; standard error, 0.010).Conclusions
H. pylori clarithromycin resistance can be easily and accurately assessed by dual-labeled PNA probe-based melting curve analysis if probes are used based on the appropriate resistance-related mutations. This method is fast, simple, accurate, and adaptable for clinical samples. It may help clinicians choose a precise eradication regimen.
SUBMITTER: Jung DH
PROVIDER: S-EPMC6254629 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
Jung Da Hyun DH Kim Jie-Hyun JH Jeong Su Jin SJ Park Soon Young SY Kang Il-Mo IM Lee Kyoung Hwa KH Song Young Goo YG
Gut and liver 20181101 6
<h4>Background/aims</h4><i>Helicobacter pylori</i> eradication rates are decreasing because of increases in clarithromycin resistance. Thus, finding an easy and accurate method of detecting clarithromycin resistance is important.<h4>Methods</h4>We evaluated 70 <i>H. pylori</i> isolates from Korean patients. Dual-labeled peptide nucleic acid (PNA) probes were designed to detect resistance associated with point mutations in 23S ribosomal ribonucleic acid gene domain V (A2142G, A2143G, and T2182C). ...[more]